Showing results (111-120 of 132) with videos related to
Sort By:
Pageof 14
The American Journal of Medicine|January 25, 2006
Incremental prognostic value of changes in B-type natriuretic peptide in heart failureRoberto Latini, Serge Masson, Maylene Wong, et al.Journal of the American College of Cardiology|March 23, 2023
Supervised Exercise Training for Chronic Heart Failure With Preserved Ejection Fraction: A Scientific Statement From the American Heart Association and American College of CardiologyVandana Sachdev, Kavita Sharma, Steven J Keteyian, et al.Journal of the American College of Cardiology|December 13, 2006
Outcomes by gender in the African-American Heart Failure TrialAnne L Taylor, JoAnn Lindenfeld, Susan Ziesche, et al.Journal of the American College of Cardiology|January 9, 2007
Influence of blood pressure on the effectiveness of a fixed-dose combination of isosorbide dinitrate and hydralazine in the African-American Heart Failure TrialInder S Anand, S William Tam, Thomas S Rector, et al.European Journal of Heart Failure|February 24, 2015
Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: insights from the GISSI-HF and Val-HeFT trialsPatrick Rossignol, Serge Masson, Simona Barlera, et al.Journal of the American College of Cardiology|September 13, 2002
Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic studyMaylene Wong, Lidia Staszewsky, Roberto Latini, et al.Journal of Cardiac Failure|September 18, 2017
Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure TrialKay-Won Chang, Neil Beri, Nghia H Nguyen, et al.Circulation|March 21, 2007
Early and sustained benefit on event-free survival and heart failure hospitalization from fixed-dose combination of isosorbide dinitrate/hydralazine: consistency across subgroups in the African-American Heart Failure TrialAnne L Taylor, Susan Ziesche, Clyde W Yancy, et al.Journal of Cardiac Failure|March 31, 2009
Endothelial nitric oxide synthase (NOS3) polymorphisms in African Americans with heart failure: results from the A-HeFT trialDennis M McNamara, S William Tam, Michael L Sabolinski, et al.Circulation|November 6, 2002
Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT)Roberto Latini, Serge Masson, Inder Anand, et al.Pageof 14